Cerubidine (Daunorubicin) for Leukemia | MyLeukemiaTeam

Connect with others who understand.

sign up Log in
About MyLeukemiaTeam
Powered By

Cerubidine is a prescription medication approved by the U.S. Food and Drug Administration (FDA) to induce remission in acute forms of leukemia such as acute lymphoblastic leukemia (ALL) and acute myeloid leukemia (AML). Cerubidine is often combined with other drugs such as cytarabine in specific chemotherapy regimens. Cerubidine is also referred to by its drug name, daunorubicin.

Cerubidine is an anticancer drug used in chemotherapy. Cerubidine is a member of a drug class called anthracycline antibiotics. Cerubidine is also a topoisomerase inhibitor. Cerubidine is believed to work by damaging DNA and blocking cell division in several different ways.

How do I take it?
Cerubidine is usually administered as an intravenous infusion during chemotherapy treatment.

Side effects
The FDA-approved label for Cerubidine lists common side effects including nausea, vomiting, abdominal pain, diarrhea, hair loss, rash, mouth sores, and increased risk of infection.

Rare but serious side effects listed for Cerubidine include heart damage or inflammation, severe damage to skin at injection sites, hypersensitivity reactions, fetal harm in pregnant women, and increased risk for some types of cancer, even years after treatment has stopped.

For more details about this treatment, visit:

Cerubidine — RxList

ALL: Chemotherapy — Leukemia & Lymphoma Society

AML: Chemotherapy and Drug Therapy — Leukemia & Lymphoma Society

Continue with Facebook
Continue with Google
Lock Icon Your privacy is our priority. By continuing, you accept our Terms of use, and our Health Data and Privacy policies.
Already a Member? Log in